TILRAY brands report a strong first quarter of financial results, emphasizing continuous growth with a record Q1 $ 210 million and net income
Operating efficiency and focus on the profitability of $ 1.5 million net income, adjusted EBITDA increased from 9% to $ 10 million, and $ 34 million annually improved.
Canadian adult Canadian Cannabis gross revenues increased by 12%, maintaining a position # 1 in the expansion of income and market share. International women’s income increased by 10%
Balance reinforced to $ 265 million in cash; Net debt has been reduced to $ 4 million
Repeats EBITDA Outlook adjusted for $ 2026 – $ 72 million
New York and London and London, Ontario, October 09, 2025 (Globe Newswire) – TILRAY Brands, Inc. (“Tilray”, “Our”, “We” or “Company”) (NASDAQ. TLRY; TSX.
His Evin D. Simon, President and Chief Executive Officer, as we enter 2026 financial, the results of the first quarter of “Tilra” outlines our shareholders of our strategic vision and disciplinary balance. Our global platform positions TILRAY brands will not only participate, but also to guide, global hemp, beverages and health effects. “
Mr. Simon continued. It is available to expand access, innovation and supports the world’s responsible regulatory progress. These achievements and nominated tendencies strengthen my unbreakable belief in the trajectory of the trail of Tilra and our ability to give our investors long-term value.
Financial needs: All comparisons made in the previous year
Net incomes increased by 5% in the first quarter to $ 209.5 million compared to 200.0 million.
Gross profit in the first quarter amounted to $ 57.5 million compared to $ 59.7 million.
Gross margin in the first quarter was 27% compared to 30%.
Cannabis Net revenues increased by 5% in the first quarter to $ 64.5 million, which is $ 61.2 million.
The gross gain of greens in the first quarter amounted to $ 23.3 million compared to $ 24.2 million.
The gross Cannabis margin in the first quarter was 36% compared to 40%.
The net income of the beverages in the first quarter amounted to $ 55.7 million compared to $ 56.0 million.
The gross profit in the first quarter amounted to $ 21.3 million compared to $ 22.9 million.
The gross margin in the first quarter was 38% compared to 41%.
Net health revenues increased to $ 15.2 million in the first quarter, compared to $ 14.8 million.
The gross health margin in the first quarter was 32% and unchanged.
The distribution net income in the first quarter amounted to $ 74.0 million compared to $ 68.1 million.
The distribution of gross margin in the first quarter was 11% compared to 12%.
Net income was $ 1.5 million in the first quarter, compared to the net loss of the dollar (34.7) million.
The regulated net income increased by $ 10.0 million in the first quarter to $ 3.9 million compared to $ (6.1) million.
Settled EBITDA increased by 9% in the first quarter to $ 10.2 million compared to $ 9.3 million.
Cash flow. The cash used in the operation has significantly improved by $ 34.0 million (1.3) million (35.3) million.
Balance update. In the first quarter, TILRAY reduced its outstanding debt for $ 7.7 million, further strengthening the balance. As a result, the net debt ratio related to the twelve months adjusted EBITDA was reduced to 0.07X. Our $ 264.8 million in cash is providing great tiltric flexibility for strategic opportunities.
Live audio web web
These results in the morning 8: 30 o’clock at 8 o’clock. On 30, web brands will be conducted to discuss these results. Investors can connect to the Department of Measures and Presentations of LIVEST Investors. Reproduction will be presented on the company’s website.
About TILRAY brands
TILRAY Brands, Inc. (Nasdaq: TLRY; TSX; TSX
For more information on how we raise life through communication moments, visit Tilray.com and follow all the social platforms of @ TILRAY.
NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number
You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.
friends,
I’m a big fan of artificial intelligence, although I have many concerns about its use. Some of the areas where I think AI can help society are healthcare diagnostics and drug discovery, finance, manufacturing, retail, logistics and technology. Workday, a publicly traded HR technology company, was discussed the ways that AI can and will affect certain industries in an article last summer.
I don’t follow WDAY closely, but the stock is down 40.8% so far in 2026, although this weakness is not unique to this stock. I have been and remain bearish on stocks, especially large-cap stocks, but I bought a tech ETF, the State Street SPDR S&P 500 Software & Services ETF, which is down 23.1% for the day. It also includes some very large companies and some that I really like. The reason these stocks have fallen so much appears to be concerns about AI, which could lead to the demise of software as a service (SaaS).
As a fan of AI, but someone who is concerned about it, I’ve been paying close attention to it even though I’m not paying for any of the services. I started using ChatGPT last year and tested it with the world I know, cannabis stocks. I was not satisfied with the answers to my questions. I recently started using Claude which I like better. I’ve never written about AI and how it can help (or hurt) people trying to pick good cannabis stocks, but I’m thinking today because I don’t think the answers are quite right.
As an analyst who has followed this industry closely for over 13 years, I know a lot. What I do know is that I don’t know everything about hemp stocks, and I certainly can’t accurately predict the future. I love that people can use the internet to do their research and it’s so much better than when I was a kid. The investment world then operated by fax, and investors had to deal with stockbrokers. AI can potentially take individuals further with their stock research.
I started writing this article before seeing this example that I will discuss. I want readers to know that this is an example of how Claude can come up with some pretty smart answers to questions. Asking good questions is the right thing for investors to do, but knowing what to do with those answers can be difficult. I believe that artificial intelligence is not there yet, and I base this on the answers to certain questions. I celebrate the improvement, but for those who think that choosing the right cannabis stock will lead to great results, I urge caution. This comment, in my opinion, goes beyond hemp stocks. Stock picking in general can be helped by artificial intelligence, but it is not harmless. Here is an example of a question I asked Claude and I think the answer is very helpful.
I am not trying to influence the price of Glass House Farms because I have literally zero influence on it. I have known Mark Codes for 50 years and love and respect him. I also think Glass House Farms CEO Kyle Kazan and his staff are doing good things.
As I’ve written here for a while, the hemp industry is facing many challenges, the biggest of which is 280E taxation. Will 280E be completed? When? Hemp stock traders and hemp stock investors need to understand that no one knows. There are many other challenges facing the hemp industry, and it goes beyond the US. Can AI answer the question of which direction hemp stocks will move in the right direction? Only if it says “up or down”.
So if you’re relying on AI to tell you when to buy cannabis stocks, or which ones to buy, I urge caution. If you’ve found something that you think gives investors a solid tool for success, please let me know. I wish readers the best with hemp stocks that remain in a bear market that is now more than five years old.
Sincerely,
Alan:
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 3 weeks.
Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.
Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
This data-driven, fact-based search engine will be continually updated based on new financial filings so readers can stay up-to-date. Companies must file with the SEC or SEDAR and be current to be considered for inclusion. When we launched this resource in May 2019, companies with more than $2.5 million in quarterly revenue qualified. As the industry has grown and as more companies have gone public, we have raised the minimum several times, including $5 million in October 2019, $7.5 million in June 2020, up to $10 million in November 2020, $12.5 million in August 2021, $12.5 million in August 2021, and $202 in September 2021. million dollars. hemp industry, we raised the minimum again in May 2024. The senior list has a minimum of US$50 million (C$68.4 million) and the junior list now has a minimum of US$25 million (C$34.2 million).
Note on adjusted operating income
In May 2019, we added an additional measure, Adjusted Operating Income, which we detailed in our newsletter. The calculation takes reported operating income and adjusts it for any changes in the fair value of biological assets required under IFRS accounting. We believe this adjustment improves comparability between companies under IFRS and GAAP accounting. We note that operating income can often include one-time items such as stock compensation, inventory write-offs or public listing costs, and we encourage readers to understand how these non-cash items may impact quarterly financials. Many companies have moved from IFRS to US GAAP accounting, which has reduced our need to make adjustments. Please note that our rating only includes actual reported income and non pro forma income. We also note that companies with non-hemp operations must provide segment-level financial statements detailing not only revenue but also operating profit in order for their operating profit to be included in the tracking. Currently, Jazz Pharma (NASDAQ: JAZZ ) and Tilray (TSX: TLRY ) (NASDAQ: TLRY ) do not provide this information.
Tracker inclusion updates
At the time of our last update on February 17th, 19 companies were eligible for inclusion on the senior lists, including 15 in USD and 4 in Canadian currency, while there were 11 companies on the junior lists. Now, 14 companies denominated in US dollars and 4 denominated in Canadian dollars qualify for the senior lists, for a total of 18 now. The junior list includes 10 companies denominated in US dollars and 2 in Canadian dollars. Tracking public cannabis company revenue and earnings on a combined basis now includes 30 companies. US senior listing could lose Cannabist (OTC: CBSTF ) if it fails to report its Q4 financials.
Companies that have reported since mid-February are included
Most of these companies are in December year-end and the year-end reports are almost completely done. This section introduces important changes. The next big reporting season is in mid-May, although a few companies will report before then.
Senior and Junior – US Dollar Report
Q4 reports began in late February and are still ongoing, with Glass House (OTC: GLASF ) reporting Tuesday afternoon. 7 MSOs reported more than $100 million in Q4 revenue with minimal operating income or losses. Growth has been very slow for the top 5 countries, with annual growth ranging from -8% to 6%.
None of the Big 5 MSOs have yet scheduled calls for their Q1 financials in May, although GTI has changed its policy and will not be hosting any for now. Here’s the current outlook for all of them in 2026, according to Coifin.
Curaleaf (OTC: CURLF ) (TSX: CURA ) – revenue is expected to increase 5% to $1.33 billion on adjusted EBITDA of $262.6 million, up 3%.
Green Thumb Industries (OTC: GTBIF ) (CSE: GTII ) – revenue is expected to increase 3% to $1.21 billion with adjusted EBITDA up 3% to $332.5 million.
Trulieve (OTC: TCNNF ) (CSE: TRUL ) – Revenue is expected to decline 1% to $1.17 billion and adjusted EBITDA is expected to decline 6% to $400.4 million.
Verano Holdings (OTC: VRNO ) (NEO: VRNO ) – revenue is expected to rise 1% to $829.3 million, with adjusted EBITDA expected to decline 1% to $225.9 million.
Cresco Labs (OTC: CRLBF ) (CSE: CL ) – Revenue is expected to decline 5% to $622.2 million and adjusted EBITDA is expected to decline 8% to $145.5 million.
Senior and Junior – Canadian Dollar Report
High Tide (NASDAQ: HITI ) (TSXV: HITI ) recently reported its 4th quarter, and since then, the stock has taken a nosedive.
Auxly (TSX: XLY ) (OTC: CBWTF ) has yet to report Q4.
The Public Cannabis Company Earnings Tracker by New Cannabis Ventures is not a recommendation of any company, and you should not use it as investment advice. A tilde next to a date means an approximate date. All calculations are derived from SEC or SEDAR filings. Any questions or licensing inquiries please contact us.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada released January retail sales for the country, with Cannabis sales are declining from December levels, down 8.4% to C$466.1 million, an all-time monthly high. The sequential decrease increased by the same 8.4% on a daily basis due to the same number of days compared to the previous month. December, originally reported at C$503.7 million, was revised slightly higher to C$508.6 million. December sales rose 6.4% from a year ago, up from May’s 8.3% and June’s 7.5%, but better than the previous lowest annual growth since legalization began in September 2024 of -0.9% and -1.6% in October due to the BC strike. Growth was much slower in December at just 3.9%. Total sales are expected to increase by 4.5% to C$5.39 billion in 2024 and by 4.1% to C$5.62 billion in 2025.
An increase in the number of shops as well as a fall in the prices of flowers that attract consumers from the illegal market have boosted sales. In Ontario, the most populous province, sales fell 8.6% from December and 4% from a year ago. Alberta was down 4.7% from December, but up 1% from a year ago. British Columbia was down 9.5% from December but up 31% from a year ago, while Quebec was down 12.5% from December but up 29% from a year ago.
February sales data will be released on April 24.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
